No Data
Jieya Co., Ltd.: Report for the first quarter of 2025
Jieya Co., Ltd.: 2024 Annual Report Summary
Jieya Co., Ltd.: 2024 Annual Report
Jieya Co., Ltd. (301108.SZ): Net income for 2024 is 19.4648 million yuan, a year-on-year decrease of 83.10%.
On April 24, Gelonghui reported that Jieya Co., Ltd. (301108.SZ) published its annual report for 2024. During the reporting period, the company achieved a revenue of 0.547 billion yuan, a decrease of 12.07% year-on-year. The net income attributable to the owners of the parent company was 19.4648 million yuan, down 83.10% year-on-year. It is proposed to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders, and to distribute 4 additional shares for every 10 shares to all shareholders from the capital surplus.
A-share midday review: The Shanghai Composite Index fell by 0.07%, the CSI Consumer 360 index rose significantly.
As of the lunch break, the Shanghai Composite Index fell 0.07% to 3,260.55 points, the Shenzhen Component Index dropped 0.43%, and the Chinext Price Index decreased by 0.29%.
Is Tongling Jieya Biologic Technology Co., Ltd.'s (SZSE:301108) Stock Price Struggling As A Result Of Its Mixed Financials?
Returns On Capital Signal Tricky Times Ahead For Tongling Jieya Biologic Technology (SZSE:301108)
